We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$771M
AUM Growth
+$32.5M
Cap. Flow
+$15.2M
Cap. Flow %
1.97%
Top 10 Hldgs %
16.24%
Holding
916
New
72
Increased
419
Reduced
247
Closed
78

Sector Composition

Rank Sector Weight
1 Financials 10.7%
2 Healthcare 10.11%
3 Consumer Discretionary 9.02%
4 Technology 8.48%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
51
Illumina
ILMN
$29.4B
$2.67M 0.35%
15,833
-79
-0.5% -$13.7K
GS icon
52
Goldman Sachs
GS
$313B
$2.65M 0.34%
11,919
+1,083
+10% +$241K
COST icon
53
Costco
COST
$415B
$2.5M 0.33%
15,661
+3,393
+28% +$585K
NOBL icon
54
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$2.47M 0.32%
85,642
-16,814
-16% -$481K
REGL icon
55
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.77B
$2.47M 0.32%
48,008
-200
-0.4% -$10.3K
PPIH
56
Perma-Pipe International
PPIH
$204M
$2.47M 0.32%
308,394
-716
-0.2% -$5.63K
PFF icon
57
iShares Preferred and Income Securities ETF
PFF
$13.2B
$2.46M 0.32%
62,798
-2,526
-4% -$98.3K
TRTN
58
DELISTED
Triton International Limited
TRTN
$2.45M 0.32%
73,173
-3,175
-4% -$93.8K
QCOM icon
59
Qualcomm
QCOM
$176B
$2.44M 0.32%
44,225
+1,609
+4% +$89.9K
TEVA icon
60
Teva Pharmaceuticals
TEVA
$35.9B
$2.4M 0.31%
72,147
+16,980
+31% +$526K
HON icon
61
Honeywell
HON
$77.1B
$2.38M 0.31%
19,767
-22
-0.1% -$2.6K
DD icon
62
DuPont de Nemours
DD
$18.6B
$2.31M 0.3%
14,472
+1,640
+13% +$261K
C icon
63
Citigroup
C
$222B
$2.22M 0.29%
33,246
+598
+2% +$36.7K
PM icon
64
Philip Morris
PM
$301B
$2.21M 0.29%
18,832
+4,123
+28% +$478K
MDC
65
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.13M 0.28%
75,793
-7,029
-8% -$184K
USB icon
66
US Bancorp
USB
$99.6B
$2.12M 0.27%
40,785
+6,802
+20% +$350K
BKNG icon
67
Booking.com
BKNG
$138B
$2.11M 0.27%
28,150
+575
+2% +$42.2K
AGN.PRA
68
DELISTED
Allergan plc
AGN.PRA
$2.1M 0.27%
2,417
-18
-0.7% -$15.1K
MA icon
69
Mastercard
MA
$477B
$2.1M 0.27%
17,254
+1,147
+7% +$136K
MRK icon
70
Merck
MRK
$324B
$2.09M 0.27%
34,162
-23
-0.1% -$1.4K
CSQ icon
71
Calamos Strategic Total Return Fund
CSQ
$3.21B
$2.04M 0.26%
173,447
+1,234
+0.7% +$14.3K
GD icon
72
General Dynamics
GD
$105B
$2.03M 0.26%
10,239
+471
+5% +$92.3K
ULTA icon
73
Ulta Beauty
ULTA
$20.4B
$2.01M 0.26%
6,998
+165
+2% +$48.2K
IVV icon
74
iShares Core S&P 500 ETF
IVV
$876B
$1.99M 0.26%
8,192
+1,022
+14% +$247K
PEP icon
75
PepsiCo
PEP
$186B
$1.99M 0.26%
17,247
+2,922
+20% +$335K

Similar funds

Wedbush Securities's Q2 2017 Portfolio in Review

As of Q2 2017, Wedbush Securities held 916 positions worth $771M, up 4.4% from $738M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q2 2017 filing shows 72 new, 419 increased, 247 reduced and 78 closed positions. Its largest new stake was Novo Nordisk: 75,326 shares worth $1.61M. The largest sale was Trc Companies, an estimated $9.24M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Wedbush Securities's largest Q2 2017 buy was Novo Nordisk: 75,326 shares worth $1.61M.
  • Wedbush Securities added most to Apple in Q2 2017, an estimated $804K increase.
  • Wedbush Securities's biggest Q2 2017 reduction was GGP Inc., cutting an estimated $1.5M.
  • Wedbush Securities fully exited Trc Companies in Q2 2017, selling an estimated $9.24M.
  • Wedbush Securities's ten largest holdings make up 16% of its $771M portfolio in Q2 2017.
  • Wedbush Securities opened 72 new positions and closed 78 in Q2 2017.
  • Wedbush Securities's portfolio value rose 4.4% quarter-over-quarter to $771M.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.